SenesTech Inc. (NASDAQ: SNES) Posts Fiscal Year 2023 Results; Reports Revenue Growth, and Gross Margin and Operating Expense Improvement
This success has been attributed largely to the company’s development and recent release of its Evolve soft bait product, a key addition to its growing product line Year to date 2024, SenesTech reported 80% year-to-date revenue growth compared to the same period in 2023 Going forward, the company looks to introduce a soft bait contraceptive product for mice, having proven that its products work effectively on rats SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just released its financial results for the 2023 financial year. Of note…